Contraceptives serve the dual purpose of protecting people from pregnancy & sexually transmitted diseases. According to Hexa Research, the global contraceptives market is predicted over USD 31 million by 2024. Rising HIV incidences & effective contraceptives would propel the industry during 2016 to 2024 (forecast period). Demand for the prevention of unwanted pregnancies & sexually transmitted infections (STIs) drive the market. Moreover, supportive policies propel industry growth. Awareness regarding unwanted pregnancies and STIs can have a positive impact on the industry in the near future. Demand for population control and expenses with respect to unwanted pregnancies should augur well for the industry.
The global Contraceptives Market is projected to experience profitable expansion till 2024. This can be ascribed to its extensive product portfolio. Other factors that drive industry flow are teenage pregnancies, awareness about modern contraception, and broader adoption of oral pills. However, dangers linked with the adoption of contraceptives may hinder industry progress. Additionally, alternative contraceptive procedures and lack of social acceptance should prevent the market from growing further. The industry is classified on the basis of products, end-users, and geographical regions.
Products include vaginal implants, femdoms & condoms, diaphragms, oral pills, subdermal implants, IUDs, and sponges. Oral pills occupied the largest shares and generated over USD 12 million in 2014. Sponges and condoms, being convenient & affordable, would sharply boost industry sales. Femdoms are poised to achieve considerable growth in the eight years ahead. Enhanced access to them will propel their demand.
All the aforementioned products accounted for huge sales due to HIV/other STI incidences and effectivity of condoms to prevent the same. According to a research, subdermal implants have been found highly-effective for women wanting to plan a family or prevent unwanted pregnancies. The widely-acceptable form of long-acting reversible contraception is IUDs (intrauterine devices). IUDs captured large shares in 2015 because of higher demand from Asia Pacific and Europe. Regional gynecologists who employ IUDs for contraception are reported to prompt segment revenues in the forecast period.
Mirena, a hormonal IUD, is extensively adopted across North America & boosts industry sales. Apart from Mirena, other available brands are Jaydess, Skyla, Flexi-T, and Nova-T. Contraceptive drugs consist of topical, pills, and injectables. Pills reigned in 2015 due to their wider client-base. They met the needs of reproductive women, providing impetus to this segment. Initiatives on the use of condoms for protected sex & prevention of sexually transmitted diseases have promoted the global Contraceptives market. The demand for effective & innovative contraceptives can motivate producers to invest in research & developments.
Affordable contraceptive implants, like sino-implants (II) are anticipated to become popular in Africa and Asia. Industry end-users are hospitals, clinics, homes, and others. Hospitals offer permanent procedures, such as female & male sterilization. Clinics held considerable shares and offer services for all genders & ages. Homes generated the maximum incomes. The contraceptives market is divided further on the basis of regions. These include North America, Asia Pacific, Europe, and rest of the world. North America occupied the largest shares in 2015 because of its abortion rates and 15-44 age women base. High patient awareness in the region also contributed to its large shares.
Europe is the center of subdermal implants and IUDs. Rest of the world is predicted to grow swiftly on account of its unexplored prospects. Its massive patient-awareness, fiscal developments, and enhanced medical infrastructure account for regional expansion. Unmet contraceptive demand for around 220 million people globally is likely to push the worldwide industry. Asia Pacific has turned the tables for the industry with regards to demographics & lack of awareness. Supportive regulations pertaining to ‘sex-education’ are one of the key factors, propelling industry demand from 2016 to 2024.
Asia Pacific, led by India and China, would capture over 30% shares by 2024. Its high disposable earnings and better medical infrastructure contribute regional expansion. Sexually-transmitted infections and population campaigns in China, India, Pakistan, & Bangladesh may also boost regional sales. Favorable plans and free sample-distribution to raise awareness in the ‘rest of the world’ can drive regional demand. Some of the key companies investing in the worldwide contraceptives market are The Female Health Company; Teva Pharmaceutical Industries; Pfizer, Inc.; and Mayer Laboratories.
Recent trends in contraceptives encompass further developments & advancements in self-administrative contraceptives. Augmentation in correct decisions about pregnancy, sexual health, & reproductive health is yet another critical success factor for the industry. Multiple governmental sanctions could serve as an opportunity for developed economies. An advancement includes ‘SILCs Diaphragms’ which are convenient, non-hormonal, and reusable up to three years. Alongside being a contraceptive, they have the ability to prevent HIV and other sexually transmitted infections.
‘Sayana Press’ is injectable and packed in pre-filled disposable syringes. Its distinct delivery system makes it easily adoptable & more portable. This enables medical workers deliver these injections to women at homes or other comfortable settings. The said delivery system can hugely affect injectable contraceptives in regions wherein industry products are inaccessible. A new ‘Woman’s Condom’ has been made which is simple to use, insert, & remove. These distinctive properties make it unique from other femdoms. It is affordable and guards against HIV. ‘Origami Condoms’ (a firm) launched an innovative condom some time back. The insides of these condoms mimic natural sensations of the body and boost pleasurable sensations. They are non-rolled & highly-convenient.
A topical lotion/gel was expected to enter the industry in 2015 that would prevent ovulation & prevent pregnancy. Some firms are testing smaller IUDs that can be tolerated better. However, whenever new drugs/products are likely to be introduced, their chance of ‘trial-failures’ exists. Global industry competition will stay relatively high till 2024. Manufacturers face constant pressure to develop novel products & technologies. Revenues in the Contraceptives Market are shared by various small & big firms.
Novel product innovations as a response to the demand for modern contraceptive procedures are a prime strategy used by participants to gain traction & broaden their reach. The ‘World Contraception Day’ was kick-started by Bayer Healthcare in affiliation with multiple NGOs. It is celebrated on September 26th to spread awareness regarding contraceptives & their benefits.
